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SUMMARY
Paediatricians recognize that using the time-dependent community-acquired vs. hospital-acquired
bloodstream infection (BSI) dichotomy to guide empirical treatment no longer distinguishes
between causative pathogens due to the emergence of healthcare-associated BSIs. However,
paediatric epidemiological evidence of the aetiology of BSIs in relation to hospital admission in
England is lacking. For 12 common BSI-causing pathogens in England, timing of laboratory
reports of positive paediatric (3 months to 5 years) bacterial blood isolates were linked to in-
patient hospital data and plotted in relation to hospital admission. The majority (88·6%) of
linked pathogens were isolated <2 days after hospital admission, including pathogens widely
regarded as hospital acquired: Enterococcus spp. (67·2%) and Klebsiella spp. (88·9%). Neisseria
meningitidis, Streptococcus pneumoniae, group A streptococcus and Salmonella spp. were unlikely
to cause hospital-acquired BSI. Pathogens commonly associated with hospital-acquired BSI are
being isolated <2 days after hospital admission alongside pathogens commonly associated with
community-acquired BSI. We conﬁrm that timing of blood samples alone does not differentiate
between bacterial pathogens. Additional factors including clinical patient characteristics and
healthcare contact should be considered to help predict the causative pathogen and guide
empirical antibiotic therapy.
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INTRODUCTION
There is increasing evidence that the traditional cate-
gorization of bloodstream infections (BSIs) in children
as either community acquired (CA) or hospital
acquired (HA) is no longer adequate to guide empiri-
cal treatment of sepsis, as patients presenting from the
community may have infections that are actually
healthcare-associated (HCA) and caused by patho-
gens acquired in a healthcare setting, rather than the
community [1]. Since the 1980s, a 48-h post-admission
threshold for CA- vs. HA-BSI has commonly been
used to guide empirical antibiotic treatment based
on the different pathogens circulating in the com-
munity vs. the hospital environment [2–9]. However,
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the epidemiology of paediatric BSIs has since evolved
due to medical advances, shorter length of hospital
stay and the ability to manage complex conditions, in-
cluding those requiring the use of invasive devices, at
home. As a result, children presenting to hospital with
systemic infections may have either a CA- or
HCA-BSI, with the latter more likely to be caused
by pathogens commonly associated with HA-BSI,
which require different empirical therapy to CA-BSI
[1, 10–12]. Currently, the bacterial aetiology of pae-
diatric BSIs in relation to hospital admission in
England is unknown and evidence to guide the formu-
lation of recommendations for treatment of paediatric
BSIs is lacking.
A recent systematic review found only two regional
studies, from Canada and England, that reported the
proportions of paediatric HCA-BSI since 2000 [13].
To address this gap in our understanding of the aeti-
ology and epidemiology of paediatric BSIs in
England, we used national data to analyse the timing
of positive blood samples from children in relation to
their hospital admission for 12 common pathogens
causing BSI.
METHODS
Linked national laboratory and clinical data
We used probabilistic methods to link retrospective
national BSI microbiology surveillance data and hos-
pital administrative data (Hospital Episode Statistics;
HES) for children aged 3 months to 5 years admitted
to a National Health Service (NHS) hospital or trea-
ted by the NHS in a private hospital in England be-
tween 1 April 2009 and 31 March 2010. Children
aged 3 months to 5 years have the second highest in-
cidence rate of paediatric BSI after neonates [14].
Neonates aged <3 months were excluded to avoid
BSIs resulting from vertically transmitted pathogens
and HA-BSI acquired by babies in intensive-care
units since birth. The microbiology surveillance data
were voluntarily submitted to Public Health
England’s (PHE) database (LabBase2) by laboratories
across England. LabBase2 captures data from a sub-
stantial proportion of all positive blood specimens
(for example, 80% of cases of BSI caused by
methicillin-resistant Staphylococcus aureus (MRSA)
reported via the national mandatory reporting scheme
are also reported to LabBase2 [15].
The following patient identiﬁers were used to link
the datasets: NHS number, hospital number, date of
birth, sex and postcode. Match-weights for the prob-
abilistic linkage were calculated using the following
equation:
Match-weight = log2(m/u).
A standard reference dataset of linked LabBase2 and
HES data from 2009 to 2010 considered to be true
links was used to calculate the match-weights. The fre-
quency of match-pairs that agreed, disagreed or were
missing particular identiﬁers from this reference data-
set were summed for each patient identiﬁer (m value;
matched). The true links match-pairs were then intern-
ally cross-matched to create all possible false-match
combinations from the standard reference dataset to
calculate the frequency counts of match-pairs that
agreed, disagreed or were missing values by chance
(u value; unmatched). The match-weight threshold
for inclusion was selected following manual review
of ≤100 randomly sampled match-pair observations
per match-weight above the value of zero by K.L.H.,
and the highest match-weight for each laboratory
blood specimen report was kept above this threshold.
A χ2 test was used to assess whether the unlinked and
linked datasets were signiﬁcantly different by gender,
age and pathogen type to identify any linkage bias.
The objective of the analysis was to assess the as-
sociation between the bacterial aetiology of BSI and
the timing of positive blood specimens taken before
and during admission to hospital. Following linkage,
BSI reports were selected for inclusion in the analysis
where the pathogen was isolated between 5 days be-
fore and up to 30 days after hospital admission.
Only the ﬁrst reported positive blood specimen per
patient was included in the analysis and we focused
on 12 frequently isolated pathogens within this age
group: S. aureus [split into MRSA and methicillin-
susceptible S. aureus (MSSA) where a methicillin sus-
ceptibility result was reported], non-pyogenic strepto-
cocci, Enterococcus spp., group B streptococcus (GBS;
Streptococcus agalactiae), Streptococcus pneumoniae,
group A streptococcus (GAS; Streptococcus pyo-
genes), Escherichia coli, Klebsiella spp., Enterobacter
spp., Pseudomonas aeruginosa, Salmonella spp., and
Neisseria meningitidis.
It should be noted that the exact time in hours of a
blood specimen or the admission to hospital were not
reported in either dataset; therefore ‘day’ is the closest
approximation and may introduce a day-drift effect.
For example two patients may be admitted on the
same day, but one at 01:00 hours and other at 23:00
hours, leaving a 22-h difference. Patients may also
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have gone to an accident and emergency (A&E) de-
partment or NHS walk-in centre before being admit-
ted to hospital as an in-patient. Records for A&E
visits are held in a separate database that was not con-
sulted for this study; however, we used data on the
source of admission to explain positive blood spe-
cimens before admission to hospital. Isolates taken
52 days after admission are consistent with the
HA-BSI deﬁnition using a 48-h cut-off most widely
used in the published literature [13].
Ethics approval
Public Health England has National Information
Governance Board for Health and Social Care
(NIGB) approval for the collation of surveillance
data in accordance with section 251 of the NHS Act
2006.
RESULTS
Linkage of national laboratory and clinical data
There were 3743 reports of positive blood samples
from children aged 3 months to 5 years during the
study period, of which 89% (n= 3314) linked to
HES records (Fig. 1); patient identiﬁer completion
was poor in the unlinked records (21% lacked NHS
number, 31% lacked postcode). The type of pathogen
was signiﬁcantly different between the linked and
unlinked datasets (χ2 P = 0·001). There was a higher
proportion of GAS (8·2% vs. 3·9%), N. meningitidis
(7·2% vs. 4·7%) and GBS (1·6% vs. 0·3%) in the
unlinked compared to the linked datasets, and a
lower proportion of S. pneumoniae (5·6% vs. 8·1%)
and non-pyogenic streptococci (5·6% vs. 8·1%) in the
unlinked dataset compared to the linked dataset; age
and gender distributions were not signiﬁcantly differ-
ent. Of these, 124 isolates were removed if they did
not occur between 5 days before and 5 days after hos-
pital admission, and 513 subsequent blood specimens
were removed so that only the index BSI case per child
remained, leaving a total of 2677 isolates.
A total of 1386 index BSI records for the 12 com-
mon pathogens were reported for cases where the
pathogen was isolated from blood between 5 days be-
fore and 30 days after admission to hospital. Of these,
57% were male and the median age was 1·73 years.
Characteristics of BSI caused by different pathogens
The number of positive blood samples together with
their timing in relation to hospital admission is
shown for each pathogen in Figure 2. Seventy (5%)
patients had a positive blood specimen 2 days
(n = 68) or >2 days (n= 2) before their admission to
hospital. Of the 68 cases, 55 were admitted as emerg-
ency cases to hospital from the A&E department,
seven were admitted as emergency cases from other
sources including the A&E department of other
Fig. 1. Flow diagram illustrating the inclusion criteria for the linked national laboratory and clinical data. HES, Hospital
Episode Statistics
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healthcare providers, three were emergency cases from
general practitioners (GPs), one case was transferred
from another hospital, one case had a planned elective
admission and one case was admitted from an out-
patient clinic. For the remaining two cases, the case
whose blood specimen was taken on day 3 was admit-
ted from the A&E department; the case whose blood
specimen was taken 5 days before admission was an
emergency GP admission.
Table 1 reports that 88·6% [95% conﬁdence interval
(CI) 88·5–88·7] of all 12 pathogen groups (range 60–
98%), were isolated <2 days after hospital admission.
Grouped by speciﬁc pathogens, 67·2% (95% CI 46·6–
84·2) of Enterococcus spp., 88·9% (95% CI 49·0–100)
of Klebsiella spp. and 64·0% (95% CI 0–100) of P. aer-
uginosa, and over 90% of all streptococci were isolated
<2 days after hospital admission. Ninety-ﬁve per cent
of S. pneumoniae, GAS, N. meningitidis, Salmonella
spp. and GBS were isolated <2 days after hospital
admission. Full details are shown for all pathogens
causing BSIs between 5 days before and 30 days
after hospital admission (n= 2435) in Supplementary
Appendix A (online).
DISCUSSION
Almost 90% of BSIs for 12 common pathogens in chil-
dren aged 3 months to 5 years were isolated from
samples taken <2 days after hospital admission. As
expected, this proportion was even higher for patho-
gens that are viewed as predominantly community
acquired (S. pneumoniae, GAS, Salmonella spp.,
N. meningitidis). The ﬁnding that over two-thirds of
pathogens (such as Enterococcus spp., Klebsiella
spp., P. aeruginosa), which are usually considered to
be hospital acquired, were isolated <2 days after hos-
pital admission, indicates that children presenting with
Fig. 2. Distribution of the timing of positive blood specimens in relation to hospital admission (day = 0) for the 12 most
frequently reported pathogen groups. The dotted line illustrates 2 days threshold after hospital admission.
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BSIs to hospital are likely to reﬂect a mixture of CA-
and HCA-BSIs [13].
The overall high proportion of BSIs that were
detected <2 days after admission is similar to the
81% proportion of CA- and HCA-BSI reported by
Laupland et al. for children aged 30 days to <18
years in Canada [5]. Evidence is lacking on the timing
of positive samples of BSI by pathogen in relation to
hospital admission for children in England; an
English, one-centre study reported BSIs in children
by pathogen but only distinguished between children
with and without serious underlying medical condi-
tions rather than CA- or HA-BSI due to a recognition
of the changing epidemiology of pathogens causing
BSIs and the emergence of HCA infections [16].
The data linkage results, along with our previous
review of the paediatric literature and other studies
in adult patients argue that the timing of positive
blood specimens in relation to hospital admission is
insufﬁcient on its own to differentiate CA- from
HCA-BSI in order to inform empirical antibiotic ther-
apy [10, 13]. Further analysis of these linked data is
needed to develop statistical models to identify patient
and clinical characteristics such as age, previous
healthcare contact, invasive procedures and underly-
ing chronic conditions that may help to differentiate
CA-, HCA- and HA-BSI and to guide empirical
treatment.
SUPPLEMENTARY MATERIAL
For supplementary material accompanying this paper
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Table 1. The proportional distribution by time of 12 pathogen groups of 1386 positive bacterial isolates between
5 days before and 30 days after hospital admission in children aged 3 months to 5 years, England
Gram Pathogen
Total no.
reported
Days either side of admission to hospital (day = 0)
−5 d to
+1 d (95% CI)
+2 to
+5 d (95% CI)
+6 to
+30 d (95% CI)
Positive Staphylococcus aureus 227 83% (81–85) 5% (4–6) 12% (11–15)
MSSA 187 85% (82–88) 5% (4–7) 10% (8–13)
MRSA 7 86% (0–100) 0% (0–100) 14% (0–100)
Non-pyogenic streptococcus† 331 92% (91–93) 5% (4–6) 3% (3–4)
Enterococcus spp. 61 67% (47–84) 8% (0–24) 25% (10–44)
Group B streptococcus 8 88% (0–100) 0% (0–100) 13% (0–100)
Streptococcus pneumoniae 253 95% (94–96) 4% (3–5) 1% (1–2)
Group A streptococcus 123 98% (94–99) 2% (1–6) 0% (0–3)
Negative Escherichia coli 113 80% (72–95) 8% (5–14) 12% (9–19)
Klebsiella spp. 36 89% (49–100) 0% (0–27) 11% (0–50)
Enterobacter spp. 25 60% (0–100) 8% (0–76) 32% (0–100)
Pseudomonas aeruginosa 25 64% (0–100) 8% (0–76) 28% (0–100)
Salmonella spp. 33 79% (28–100) 18% (0–67) 3% (0–40)
Neisseria meningitidis 151 98% (96–99) 2% (1–4) 0% (0–2)
Total* 1386 89% (89–89) 5% (4–6) 7% (7–7)
CI, Conﬁdence interval.
* The total does not double count the Staphylococcus aureus isolates tested for methicillin susceptibility [methicillin-
susceptible S. aureus (MSSA), methicillin-resistant S. aureus (MRSA)].
†Non-pyogenic streptococci includes: Abiotrophia defectiva, Aerococcus spp., S. acidominimus, S. alactolyticus, S. anginosus,
S. bovis, S. constellatus, S. dysgalactiae, S. gordonii, group C streptococcus, group D streptococcus, S. intermedius, S. milleri
group, S. mitior, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. salivarius, S. sanguinis, S. sobrinus, S. uberis, S. vestibularis,
S. viridans, other Streptococcus spp.
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HES data. Copyright © 2012, re-used with the per-
mission of The Health and Social Care Information
Centre. All rights reserved.
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